Utilization of HCV Viremic Kidneys with Genotyping/Subtyping-Free Sofosbuvir/Velpatasvir Treatment Strategy: Experience from China

Figure 2

Comparison of trends in serum creatinine and eGFR posttransplant between HCV D+/R- group and D+/R+ group.